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Figure S1. This figure is related to Figure 1. 
(A) (Left) Cell-sorting strategy used for isolation of BAT CD45+ cells before scRNA-Seq and (right) Single Cell 
RNA-Seq analysis of Ptprc expression among BAT CD45+ cells (B) Breeding scheme for generating Adipo∆/∆ 
mice. (C) TdTomato reporter expression (red) in epididymal (EAT) and brown (BAT) adipose tissues by 
fluorescence microscopy. (D) ATGL protein expression in Adipo∆/∆ mice brown adipose tissue (BAT) compared 
to controls (Ctrl) by Western Blot analysis; HSP90 was used as loading control for protein expression. (E) 
Glycerol levels in control (n=18) and Adipo∆/∆ (n=20) mice sera. p= 0,0096. (F) Myristic acid (C14:0), palmitic 
acid (C16:0) and a-linoleic acid (C18:3 n-3) levels in control (n=7) and Adipo∆/∆ (n=9) mice sera. p=0,0003 (left), 
p=0,0115 (middle), p= 0,0418 (right). (G) Lipidomic analysis of serum from control and Adipo∆/∆ mice. Data are 
represented in ratio compared to Ctrl condition ± SEM. Stars indicate a statistically significant difference 
between controls and Adipo∆/∆ mice (p<0,05). 
Panel C is representative of 3 experiments. Panel D represents one experiment. Panel E represents pooled 
data from 5 independent experiments. Panels F and G represent pooled data from 2 independent experiments. 
All data are represented in means ± SEM. Two-tailed Mann Whitney tests were used to determine statistical 
significance in panels E and F. ns p>0,05 ; * p<0,05 ; **<0,01 ; *** p<0,001 ; **** p<0,0001. Source data, and 
notably uncropped blots for panel S1D, are provided as a Source Data file. 
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Name Formula Ratio compared to ctrl +/- SEM
Laureic acid C12:0 1,0437643 0,0457
Myristic acid * C14:0 0,47300615 0,0328
Palmitoleic acid C16:1 n-9 0,96329024 0,1434
Methyl palmitoleic acid * C16:1 n-7 0,57340346 0,07513
Palmitic acid * C16:0 0,73588931 0,06703
Oleic acid C18:1 n-9 0,74614637 0,08332
Trans-vaccenic acid C18:1 n-7 0,93253779 0,1181
Stearic acid C18:0 0,83793297 0,05683
linoleic acid C18:2 n-6 0,83610225 0,04359
α-linolenic acid * C18:3 n-3 0,7386928 0,03713
cis-11-Eicosenoic acid C20:1 n-9 0,8906383 0,09488
dihomo-γ-linolenic acid C20:3 n-6 0,92904146 0,1156
Mead acid C20:3 n-9 0,89803058 0,1329
Arachidonic acid C20:4 n-6 0,9339235 0,109
Eicosapentaenoic acid C20:5 n-3 1,00486347 0,1208












































































































































































































































































































































Figure S2. This figure is related to Figure 2. 
(A) Single Cell RNA-Seq analysis of the PID “lysophospholipid metabolism” pathway, the KEGG “glycerolipid 
metabolism” gene set and the KEGG “glycerophospholipid metabolism” gene set expression. (B) Single Cell 
RNA-Seq analysis of Mrc1 and CD226 expression among BAT monocytes and macrophages. (C) Gating 
strategy used for identification of tissue macrophages, and tissue monocytes in mice lacking the CX3CR1gfp 
reporter. (D) Representative dot plots (left) and proportions (right) of BAT and EAT CD206high and CD226high 
macrophages in Adipo∆/∆ mice (n=11). p=0,0788 (left), p<0,0001 (right). (E) Quantification of EAT macrophage 
and monocyte counts in control (n=11) and Adipo∆/∆ (n=16) mice using flow cytometry. p=0,3607 (left), p=0,1207 
(right). (F) Quantification of BAT monocyte and macrophage numbers in control (n=6) and BAT∆/∆ (n=4) mice 
using flow cytometry. p= 0,0095 (left and right). (G) Quantification of surface MHCII expression on EAT 
monocytes in control (n=14) and Adipo∆/∆ mice (n=15) using flow cytometry. p=0,9095. (H) Quantification of 
surface CD206 and CD301 expression by EAT macrophages in control (n=11) and Adipo∆/∆ (n=16) mice using 
flow cytometry. p=0,6905 (left and right). (I) Single Cell RNA-Seq analysis of Mrc1 (CD206) and Clec10a 
(CD301) expression among BAT myeloid cells. (J) Single Cell RNA-Seq analysis of genes involved in cell 
proliferation. 
Panel D represents pooled data from 2 independent experiments. Panels E, G and H represent pooled data 
from 4 independent experiments. Panel F is representative from 2 independent experiements. All data are 
represented in means ± SEM. Two-tailed Mann Whitney tests were used to determine statistical significance. 




































Figure S3. This figure is related to Figure 3. 
(A) (Top panel) Representative photos showing the enlarged BAT in Adipo∆/∆ mice compared to control groups 
16 days post-tamoxifen administration. (Bottom panel) Representative autoradiography images showing the 
increased 64Cu-DOTA-ECL1i signals in the BAT of Adipo∆/∆ mice compared to control groups 16 days post-
tamoxifen administration. (B) Representative dot plots of blood monocytes in control and Adipo∆/∆ mice. (C) 
Quantification of blood neutrophil, T cell and B cell counts in control (n=12) and Adipo∆/∆ (n=14) mice using flow 
cytometry. p=0,4428 (left), p=0,5826 (middle), p=0,6848 (right). (D) Quantification of bone marrow LSK (Lin- 
Sca1+ cKit+) and monocytes in control (n=9 and 13 respectively) and Adipo∆/∆ (n=10 and 14 respectively) mice 
using flow cytometry. p=0,4002 (left) and p=0,0850 (right). (E) Bone marrow monocyte proliferation rate and 
survival in control (n=4 and n=5 respectively) and Adipo∆/∆ (n=8 and n=7 respectively) mice by flow cytometry. 
p=0,3144 (left), p=0,0657 (right). (F) Schematic representation of Brdu injection protocol to visualize monocyte 
export from bone marrow to blood (left) and its quantification by flow cytometry in control (n=5) and Adipo∆/∆ 
mice (n=7). p= 0,1490. 
Panels C and D represent pooled data from 4 independent experiments. Panel E (left) represents pooled data 
from 2 independent experiments. Panels E (right) and F are representative of one experiment. All data are 
represented in means ± SEM. Two-tailed Mann Whitney tests were used to determine statistical significance. 





















































































































































Figure S4. This figure is related to Figure 4. 
(A) Representative dot plots (left) and quantification (right) of blood and spleen monocytes in MC-21 (n=13 and 
15 respectively) or vehicle-treated (n=15 and 18 respectively) Adipo∆/∆ mice. p= 0,0002 (left) and p<0,0001 
(right). (B) (Left panel) EAT weight of MC-21 or vehicle-treated control (n=5 and 6 respectively) and Adipo∆/∆ 
(n=15 and 18 respectively) mice and (right panel) EAT adipocyte diameter measurement. p>0,05 (all 
comparisons). (C) Quantification of crown-like structures (CLS) (left) ) and immunofluorescence microscopy 
analysis in BAT of control (n=10) and MC-21-treated (n=9) Adipo∆/∆ mice. CX3CR1+/+ samples were used to 
determine background signal. White stars indicate crown-like structures. Scale bar = 100um. p=0,0364. (D) 
Glycerol, TG and NEFA levels in the serum of control (n=17) and MC-21-treated (n=15) Adipo∆/∆ mice. p= 0,2948 
(left), p= 0,5800 (middle) and p= 0,4474 (right). 
Data were obtained from 3 pooled independent experiments. All data are represented in means ± SEM. Two-
tailed Mann Whitney tests were used to determine statistical significance. ns p>0,05 ; * p<0,05 ; ** p<0,01 ; *** 


















































































































































































Figure S5. This figure is related to Figure 5. 
(A) a-SMA staining (red) in the BAT of Adipo∆/∆ mice. Autofluorescence signal (green) is used to show tissue 
architecture. Data representative of 2 independent experiments. (B) Histograms showing CLEC-2 and FMO 
stainings among BAT monocytes and macrophages from Adipo∆/∆ mice. Data representative of 2 independent 
experiments. (C) (Left) Quantification of MEF morphological features after a 18hour co-culture experiment with 
monocytes in the presence of anti-Podoplanin blocking antibody. (Right) Representative images of MEF 
morphology at the end of the co-culture experiment. Scale bar = 20µm. p=0,3784 (left) and p=0,9203 (right). 
Data representative of 2 independent experiments. (D) Quantification of BAT macrophage and monocyte 
numbers in anti-Podoplanin (n=8) and isotype control-treated (n=10) Adipo∆/∆ mice using flow cytometry. (E) 
Glycerol, TG and NEFA levels in the serum of isotype control (n=10) and anti-Podoplanin-treated (n=8) Adipo∆/∆ 
mice. Data were obtained from 2 pooled independent experiments. 
Panel C is representative of 2 independent experiments. Panels D and E represent pooled data from 2 pooled 
independent experiments. All data are represented in means ± SEM. Two-tailed Mann Whitney tests were used 
to determine statistical significance. ns p>0,05 ; * p<0,05 ; ** p<0,01 ; *** p<0,001 ; **** p<0,0001. Source data 








































































































































































































































































Supplementary Table 1 
Primers used for genotyping and RT-qPCR. 
 
 
Mouse RT-qPCR Primer sequences 
Gene name Primer Forward (Left) Primer Reverse (Right) 
GAPDH ACCACAGTCCATGCCATCACTGCCA GGCCATCCACAGTCTTCTGC 
ß-Actin GAGACCTTCAACACCCC GTGGTGGTGAAGCTGTAGGC 
CXCL12 CCAAACTCTCCCCTTCAGAT ATTTCGGGTCAATGCACACT 
CCL2 CATCCACGTGTTGGCTCA GATCATCTTGCTGGTGAATGAGT 
TNF-a CACAAGATGCTGGGACAGTGA TCCTTGATGGTGGTGCATGA 
 
 
Supplementary Table 2 
List of reagents, materials, models and software used. 
 




CD115 PE (clone AFS98) eBioscience Cat# 12-1152-82 
CD11b Brilliant Violet 510 (cloneM1/70) Biolegend Cat# 101263 
Gr1 PerCP-Cy5.5 (clone RB6-8C5) BD Biosciences Cat# 552093 
Ly6C PerCP-Cy5.5 (clone HK1.4) Biolegend Cat# 128011 
F4/80 PE-Cy7 (clone BM8) Biolegend Cat# 123114 
CD45 APC-Cy7 (clone 30-F11) BD Biosciences Cat# 557659 
CD64 Brillant Violet 421 (clone X54-5/7.1) Biolegend Cat# 139309 
CD19 FITC (clone 6D5) Biolegend Cat# 115506 
CD301 FITC (clone ER-MP23) Bio-Rad Cat# MCA2392 
MerTK PE (clone 2B10C42) Biolegend Cat# 151506 
CD11c PE-Cy7 (clone HL3) BD Biosciences  Cat# 558079 
MHC II IA/IE APC (clone M5/114.15.2) Biolegend Cat# 107618 
CD206 PerCp-Cy5.5 (clone C068C2) Biolegend Cat# 141715 
CD206 AF647 (clone C068C2) Biolegend Cat# 141712 
CD226 PerCp-Cy5.5 (clone10E5) Biolegend Cat# 128813 
Clec2 PE (clone 17D9/CLEC-2) Biolegend Cat# 146103 
TCRb PB (clone H57-597) Biolegend Cat# 109226 
CD3 APC (clone 17A2) Biolegend Cat# 100236 
NK1.1 APC (clone PK136) Biolegend Cat# 108720 
Ter119 APC (clone TER-119) Biolegend Cat# 116212 
B220 APC (clone RA3-6B2) BD Biosciences Cat# 561226 
CD19 APC (clone REA749) Miltenyi Biotec Cat# 130-111-884 
CD150 PE-Cy7 (clone TC15-12F12.2) Biolegend Cat# 115914 
Sca1 PB (clone D7) Biolegend Cat# 108120 
c-Kit APC-Cy7 (clone ACK2) eBioscience Cat# 47-1172-82 
CD48 AF488 (clone HM48-1) Biolegend Cat# 103414 
Mouse Genotyping Primer sequences 
Gene name Primer Forward (Left) Primer Reverse (Right) 
GAPDH ACCACAGTCCATGCCATCACTGCCA GGCCATCCACAGTCTTCTGC 
ß-Actin GAGACCTTCAACACCCC GTGGTGGTGAAGCTGTAGGC 
CXCL12 CCAAACTCTCCCCTTCAGAT ATTTCGGGTCAATGCACACT 
CCL2 CATCCACGTGTTGGCTCA GATCATCTTGCTGGTGAATGAGT 
TNF-a CACAAGATGCTGGGACAGTGA TCCTTGATGGTGGTGCATGA 
CXCR4 APC (clone 2B11) eBioscience Cat# 51-9991-80 
CD11b APC (clone M1/70) Biolegend  Cat# 101218 
MC-21 Dr Mack M.   
Podoplanin (clone 8.1.1) BioXCell Cat# BE0236 
InVivoMAb polyclonal Syrian hamster IgG BioXCell Cat# BE0087 
Ly6G Biotin (clone REA526) Miltenyi biotec Cat# 130-116-512 
CD3 Biotin (clone REA641) Miltenyi biotec Cat# 130-123-861 
B220 Biotin (clone REA755) Miltenyi biotec Cat# 130-110-844 
NK1.1 Biotin (clone REA1162) Miltenyi biotec Cat# 130-120-513 
Ter-119 Biotin (clone Ter-119) Miltenyi biotec Cat# 130-120-828 
SiglecF Biotin (clone REA798) Miltenyi biotec Cat# 130-112-329 
a-SMA Abcam Cat# ab5694 




DAPI Sigma Cat# D9542 
Phalloidin Texas Red Invitrogen Cat# T7471 
PFA 4% VWR International Cat# 9713.1000 
Bovine serum Albumin (BSA) Sigma Cat# A7030 
Tamoxifen Sigma Cat# T5648 
RPMI medium Life Technologies Cat# 21875091 
DMEM medium  Life Technologies Cat# 11960044 
Collagenase A Sigma Cat# 11088793001 
IHC Antigen retrieval solution  eBiosciences Cat# 00-4955-58 
ImmunoHistoMount Sigma Cat# I1161 
Thiazolyl blue tetrazolium bromide Sigma Cat# M2128 
Fetal bovine serum  Fisher Scientific Cat# 12350273 
Lysing buffer BD Biosciences Cat# 555899 
L-Glutamine Life Technologies Cat# 25030024 
Penicillin Streptomycin Life Technologies Cat# 15070063 
Sodium Pyruvate Life Technologies Cat# 11360039 
Free glycerol reagent Sigma Cat# F6428 
Power SYBRTM green PCR Master Mix Applied Biosystems Cat# 4367659 
RIPA buffer Cell signaling Cat# 9806 
Anti-Biotin MicroBeads Miltenyi Biotec Cat# 130-090-858 
 
Critical commercial Assays 
  
High-Capacity cDNA reverse transcription 
kit 
Applied Biosystems Cat# 4368814 
CCL2 DuoSet ELISA R&D Systems Cat# DY479-05 
TNF-alpha DuoSet ELISA R&D Systems Cat# DY410-05 
RNeasy Plus Mini Kit (250) QIAGEN Cat# 74136 
Mouse CXCL12/SDF-1 DuoSet ELISA R&D Systems Cat# DY460 
(Stromal Cell Derived Factor 1), Human, 
Elisa Kit 
EUROMEDEX Cat# EH3755 
NEFA-HR2 R1 + R2 FUJFILM WAKO Cat# W1W270-
77000 
Glucose dosage Kit BioSentec Cat# 075 
Triglyceride dosage Kit DiaSys Cat# 
157109910021 
BrdU APC Staining Kit  ThermoFisher Cat# 8817-6600-42 
0.4 µm Cell culture Inserts 24 well format Falcon Cat# 353095 
   
Experimental models: Organisms/Strains 
Mouse: C57BL/6-Tg(Adipoq-
cre/ERT2)1Soff/J 
The Jackson laboratory JaxStock# 025124 
Mouse: B6.FVB-Tg(Ucp1-cre)1Evdr/J The Jackson laboratory JaxStock# 024670 
 
Mouse: B6N.129S-Pnpla2tm1Eek/J The Jackson laboratory JaxStock# 024278 
Mouse: B6.129P-Cx3cr1tm1Litt/J The Jackson laboratory JaxStock# 008451 
Mouse: B6.Cg-Gt(ROSA)26Sortm9(CAG-
tdTomato)Hze/J 
The Jackson laboratory JaxStock# 007909 
Mouse: C57BL/6NTac-Ccr2tm2982(T2A-
Cre7ESR1-T2A-mKate2] 
Dr. Burkhard Becher N/A 
Mouse: CCR2GFP  Dr. Marco Colonna N/A 
Cell line : Mouse Embryonic Fibroblasts 
(MEFs) 




StepOne Applied Biosystem N/A 
Thermo Cycler SimpliAmp Applied Biosystem N/A 
Nanodrop OZYME  
MACS Multistand Miltenyi Biotec Cat# 130-042-303 




Prism6 GraphPad N/A 
FlowJo Tree Star N/A 
Fuji Fiji N/A 
GENEsys Syngene N/A 
StepOne Software v.2.2.2 Applied Biosystem N/A 
Fiji https://imagej.net/software/fiji/ N/A 
 
